Striking while biotech is hot: Idera, KaloBios, Ampio and Fibrocell raise cash
This article was originally published in Scrip
Executive Summary
If you're a biotechnology company that needs cash to get to your next crucial milestone, now is a great time to tap public investors, just as Idera Pharmaceuticals, KaloBios Pharmaceuticals, Ampio Pharmaceuticals and Fibrocell Science did recently with various stock offerings.